Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Wellgistics Health (WGRX) Enterprise Value (2023 - 2025)

Wellgistics Health filings provide 3 years of Enterprise Value readings, the most recent being -$42571.0 for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 95.86% to -$42571.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$42571.0, a 95.86% increase, with the full-year FY2025 number at -$42571.0, up 95.86% from a year prior.
  • Enterprise Value hit -$42571.0 in Q4 2025 for Wellgistics Health, up from -$4.2 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$1364.0 in Q4 2023 to a low of -$4.2 million in Q3 2025.
  • Median Enterprise Value over the past 3 years was -$724139.0 (2024), compared with a mean of -$1.4 million.
  • Biggest five-year swings in Enterprise Value: plummeted 75291.2% in 2024 and later skyrocketed 95.86% in 2025.
  • Wellgistics Health's Enterprise Value stood at -$1364.0 in 2023, then plummeted by 75291.2% to -$1.0 million in 2024, then skyrocketed by 95.86% to -$42571.0 in 2025.
  • The last three reported values for Enterprise Value were -$42571.0 (Q4 2025), -$4.2 million (Q3 2025), and -$419942.0 (Q2 2025) per Business Quant data.